首页> 外文期刊>European Journal of Medicinal Plants >Toxicity Evaluation of a Commercial HerbalPreparation Commonly Used in Nigeria
【24h】

Toxicity Evaluation of a Commercial HerbalPreparation Commonly Used in Nigeria

机译:尼日利亚常用的商业草药制剂的毒性评估

获取原文
           

摘要

Aim: To investigate the safety of a popular polyherbal decoction, consisting of Alstonia boonei stem bark and Fagara zanthoxyloids stem bark, used in the management of arthritis and rheumatism in Nigeria.Place and Duration of Study: Department of Pharmacology and Toxicology, Nnamdi Azikiwe University, Agulu, Anambra State, Nigeria between the months of June and November, 2013.Study Design: In acute toxicity study, 2 -10 ml/kg were administered to rats and mice and obvious toxic signs and mortality were observed for 24 hours post-administration. In sub-chronic toxicity study, 1.29, 2.97 and 5.14 ml/kg, of the herbal preparation were orally administered to three groups (five animals per group) of Wistar rats daily for 90 days. The control group of animals received 10 ml/kg of normal saline. Body weight changes were determined weekly, while hematological parameters, biochemical parameters, ulcer index and liver and kidney histologies were evaluated on 31, 61 and 91st days. Post-treatment studies were also carried out.Results: All the animals survived after twenty four (24) hours of observation in acute toxicity study and the LD50 was estimated to be above 10 ml/kg. In sub-chronic toxicity studies, there were insignificant (P>.05) changes in body weight and hematological parameters. However, some blood chemistry indices were significant (P<.05). The histologies of the liver and kidney showed irreversible toxicities especially at high doses and duration of administration.Conclusion: These findings indicate that the herbal preparation may be nephrotoxic and hepatotoxic especially at high doses on long term use, suggesting that it may not be safe in the treatment of arthritis and rheumatism and other chronic diseases.
机译:目的:研究流行的多草药汤的安全性,该汤由阿尔斯通尼亚(Alstonia boonei)茎皮和Fagara zanthoxyloids茎皮组成,用于尼日利亚的关节炎和风湿病的治疗。研究设计:在急性毒性研究中,对大鼠和小鼠进行了2 -10毫升/千克的急性毒性研究,在麻醉后24小时内观察到明显的毒性体征和死亡率。行政。在亚慢性毒性研究中,每天向三组Wistar大鼠(每组五只动物)口服1.29、2.97和5.14 ml / kg的草药制剂,持续90天。对照组动物接受10ml / kg的生理盐水。每周测定体重变化,同时在第31、61和91天评估血液学参数,生化参数,溃疡指数以及肝肾组织学。结果:所有动物在急性毒性研究中观察二十四(24)小时后均存活,并且LD50估计超过10 ml / kg。在亚慢性毒性研究中,体重和血液学参数变化不明显(P> .05)。但是,某些血液化学指标很显着(P <.05)。肝脏和肾脏的组织学表现出不可逆的毒性,尤其是在高剂量和持续时间的情况下。结论:这些发现表明,该草药制剂可能具有肾毒性和肝毒性,尤其是在长期服用高剂量的情况下,表明该制剂可能不安全。治疗关节炎和风湿病等慢性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号